Skip to main content
logo
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.310
-0.300 (-8.31%)
Oct 30, 2026, 4:00 PM EST - Market closed

Psyence Biomedical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
13631597327
Market Cap Growth
557.94%107.69%-82.20%-84.31%-70.26%-
Enterprise Value
5-2215--
Last Close Price
3.312.4629.894258.9839616.7437396.84

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--2.69---
PB Ratio
0.450.330.40-1.39-485.22192.35
P/TBV Ratio
0.750.330.40--192.35

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
----0.95--
Net Debt / Equity Ratio
-0.44-0.44-0.91-0.886.66-1.03
Net Debt / EBITDA Ratio
1.201.201.68-3.53--
Net Debt / FCF Ratio
0.910.911.64-3.290.841.26
Quick Ratio
12.1212.1210.550.060.8313.62
Current Ratio
14.6214.6211.040.090.8913.90
Return on Equity (ROE)
-58.62%-58.62%---468.63%-
Return on Assets (ROA)
-31.33%-31.33%-54.20%-126.35%-123.25%-
Return on Capital Employed (ROCE)
-36.80%-36.80%-54.50%25.10%1613.80%-109.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-379.44%-122.95%37.25%-335.16%-3.30%-0.57%
FCF Yield
-64.50%-144.34%-137.84%-19.33%-1.64%-0.43%
Buyback Yield / Dilution
-1688.07%-1688.07%----
SEC Filings: 10-K · 10-Q